I-Rivastigmine (Exelon): yenzelwe ini nokuthi isetshenziswa kanjani

-Delile

• Yenzelwe ini
• Isetshenziswa kanjani
• Imiphumela emibi nokuphikisana

I-Rivastigmine yisidakamizwa esisetshenziselwa ukwelapha isifo i-Alzheimer's kanye nesifo sika-Parkinson, njengoba sandisa inani le-acetylcholine ebuchosheni, into ebalulekile ekusebenzeni kwememori, ukufunda nokuma komuntu.

I-Rivastigmine iyisithako esisebenzayo semithi efana ne-Exelon, ekhiqizwa ilabhorethri yeNovartis; noma i-Prometax, ekhiqizwa ilabhorethri yakwaBiossintética. Umuthi ojwayelekile wale nto ukhiqizwa yinkampani eyenza imithi i-Aché.

Yenzelwe ini

I-Rivastigmine ikhonjisiwe ekwelashweni kweziguli ezinokuwohloka komqondo okuncane kuya kokulingene kohlobo lwe-Alzheimer's, noma ezihambisana nesifo sikaParkinson.

Isetshenziswa kanjani

Ukusetshenziswa kweRivastigmine kufanele kwenziwe ngokwencomo kadokotela ojwayelekile noma udokotela wezinzwa ngokuya ngezimpawu zesiguli, ezingakhonjiswa:

• Umthamo wokuqala: 1.5 mg kabili ngosuku noma, esimweni seziguli ezizwela emithini ye-cholinergic, 1 mg kabili ngosuku.
• Ukulungiswa komthamo: ngemuva kwamasonto amabili okwelashwa umuthi ubekezeleleke kahle, umthamo ungakhuphuka kancane kancane ube ngu-3 mg, 4 mg noma u-6 mg.
• Isilinganiso sesondlo: 1.5 mg kuye ku-6 mg kabili ngosuku.

Kubalulekile ukuthi umuntu azi ngobukhona bomphumela omubi, ngoba uma kwenzeka kubalulekile ukuxhumana nodokotela futhi ubuyele kumthamo wangaphambilini.

Imiphumela emibi nokuphikisana

Imiphumela engemihle yeRivastigmine kungaba isicanucanu, ukuhlanza, isifo sohudo, ukungathandi ukudla, isiyezi, ukuthuthumela, ukuwa, ukukhiqizwa kwamathe okwandayo noma ukuwohloka kwesifo sikaParkinson.

I-Rivastigmine iyaphikiswa ezigulini ezine-hypersensitivity kunoma iyiphi ingxenye yefomula kanye nokwehluleka kwesibindi, kanye nokungakhonjiswa kwabesifazane abakhulelwe noma abancelisayo nezingane.